mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.4 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |